Funder
Shahroud University of Medical Sciences
Publisher
Springer Science and Business Media LLC
Reference87 articles.
1. Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., et al. (2016). The third international consensus definitions for Sepsis and septic shock (Sepsis-3). Jama, 315(8), 801–810.
2. Organization WH. Global report on the epidemiology and burden of sepsis: Current evidence, identifying gaps and future directions. 2020.
3. Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., et al. (2013). Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Critical Care Medicine, 41(2), 580–637.
4. Cheng, Y., Cao, X., & Qin, L. (2020). Mesenchymal stem cell-derived extracellular vesicles: A novel cell-free therapy for Sepsis. Frontiers in Immunology, 11, 647.
5. Mei, S. H., Haitsma, J. J., Dos Santos, C. C., Deng, Y., Lai, P. F., Slutsky, A. S., et al. (2010). Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. American Journal of Respiratory and Critical Care Medicine, 182(8), 1047–1057.